Artal Group S.A.

Holdings History for ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY)

Symbol: ALNY on Nasdaq
Investment type: Equity / COMMON STOCK

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2023			-0.01%	$0	0	-936	-100%	$322.28	Q4 2023
30 Sep 2023		0.01%	0%	$166,000	936	0		$177.35	Q3 2023
30 Jun 2023		0.01%	+0.01%	$178,000	936	+936	NEW	$190.17	Q2 2023
30 Sep 2022			-4.9%	$0	0	-600,000	-100%	$322.28	Q3 2022
30 Jun 2022		4.9%	-0.41%	$87,510,000	600,000	-50,000	-7.7%	$145.85	Q2 2022
31 Mar 2022		4.5%	0%	$106,139,000	650,000	0		$163.29	Q1 2022
31 Dec 2021		3.2%	-0.25%	$110,227,000	650,000	-50,000	-7.1%	$169.58	Q4 2021
30 Sep 2021		3.3%	-0.23%	$132,167,000	700,000	-50,000	-6.7%	$188.81	Q3 2021
30 Jun 2021		2.9%	0%	$127,140,000	750,000	0		$169.52	Q2 2021
31 Mar 2021		2.2%	-0.15%	$105,893,000	750,000	-50,000	-6.2%	$141.19	Q1 2021
31 Mar 2021	call		-9%	$0	0	-200,000	-100%	$322.28	Q1 2021
31 Dec 2020		2.4%	0%	$103,976,000	800,000	0		$129.97	Q4 2020
31 Dec 2020	call	9%	+9%	$25,994,000	200,000	+200,000	NEW	$129.97	Q4 2020
30 Sep 2020		3.8%	-0.48%	$116,480,000	800,000	-100,000	-11%	$145.60	Q3 2020
30 Sep 2020	call		-2.3%	$0	0	-100,000	-100%	$322.28	Q3 2020
30 Jun 2020		4.5%	-1%	$133,299,000	900,000	-200,000	-18%	$148.11	Q2 2020
30 Jun 2020	call	2.3%	+2.3%	$14,811,000	100,000	+100,000	NEW	$148.11	Q2 2020
31 Mar 2020		5.7%	+0.52%	$119,735,000	1,100,000	+100,000	+10%	$108.85	Q1 2020
31 Dec 2019		4.8%	+1.4%	$115,170,000	1,000,000	+300,000	+43%	$115.17	Q4 2019
30 Sep 2019		2.7%	+1.2%	$56,294,000	700,000	+300,000	+75%	$80.42	Q3 2019
30 Sep 2019	call		-3.6%	$0	0	-150,000	-100%	$322.28	Q3 2019
30 Jun 2019		1.3%	-0.17%	$29,024,000	400,000	-50,000	-11%	$72.56	Q2 2019
30 Jun 2019	call	3.6%	+3.6%	$10,884,000	150,000	+150,000	NEW	$72.56	Q2 2019
31 Mar 2019		2%	-0.22%	$42,053,000	450,000	-50,000	-10%	$93.45	Q1 2019
31 Mar 2019	call		-3.2%	$0	0	-300,000	-100%	$322.28	Q1 2019
31 Dec 2018		1.8%	-0.36%	$36,455,000	500,000	-100,000	-17%	$72.91	Q4 2018
31 Dec 2018	call	3.2%	+2.1%	$21,873,000	300,000	+200,000	+200%	$72.91	Q4 2018
30 Sep 2018		1.8%	-0.15%	$52,512,000	600,000	-50,000	-7.7%	$87.52	Q3 2018
30 Sep 2018	call	0.91%	0%	$8,752,000	100,000	0		$87.52	Q3 2018
30 Jun 2018		1.7%	+0.13%	$64,019,000	650,000	+50,000	+8.3%	$98.49	Q2 2018
30 Jun 2018	call	1.1%	+1.1%	$9,849,000	100,000	+100,000	NEW	$98.49	Q2 2018
31 Mar 2018		1.1%	+0.26%	$71,460,000	600,000	+150,000	+33%	$119.10	Q1 2018
31 Mar 2018	call		-2%	$0	0	-200,000	-100%	$322.28	Q1 2018
31 Dec 2017		1.1%	+0.47%	$57,173,000	450,000	+200,000	+80%	$127.05	Q4 2017
31 Dec 2017	call	2%	+2%	$25,410,000	200,000	+200,000	NEW	$127.05	Q4 2017
30 Sep 2017		0.58%	-0.06%	$29,373,000	250,000	-25,000	-9.1%	$117.49	Q3 2017
30 Jun 2017		0.49%	-0.04%	$21,934,000	275,000	-25,000	-8.3%	$79.76	Q2 2017
31 Mar 2017		0.4%	-0.26%	$15,375,000	300,000	-200,000	-40%	$51.25	Q1 2017
31 Mar 2017	call		-0.93%	$0	0	-200,000	-100%	$322.28	Q1 2017
31 Dec 2016		0.51%	-0.1%	$18,720,000	500,000	-100,000	-17%	$37.44	Q4 2016
31 Dec 2016	call	0.93%	+0.46%	$7,488,000	200,000	+100,000	+100%	$37.44	Q4 2016
30 Sep 2016		1%	-0.19%	$40,668,000	600,000	-110,000	-15%	$67.78	Q3 2016
30 Sep 2016	call	0.63%	-1.3%	$6,778,000	100,000	-200,000	-67%	$67.78	Q3 2016
30 Jun 2016		0.91%	+0.14%	$39,398,000	710,000	+110,000	+18%	$55.49	Q2 2016
30 Jun 2016	call	3.2%	+1.6%	$16,647,000	300,000	+150,000	+100%	$55.49	Q2 2016
31 Mar 2016		0.82%	+0.17%	$37,662,000	600,000	+125,000	+26%	$62.77	Q1 2016
31 Mar 2016	call	1.7%	+1.7%	$9,416,000	150,000	+150,000	NEW	$62.77	Q1 2016
31 Dec 2015		1.1%	+0.09%	$44,717,000	475,000	+40,000	+9.2%	$94.14	Q4 2015
31 Dec 2015	call		-0.34%	$0	0	-50,000	-100%	$322.28	Q4 2015
30 Sep 2015		1.1%	-0.05%	$34,957,000	435,000	-20,000	-4.4%	$80.36	Q3 2015
30 Sep 2015	call	0.34%	+0.34%	$4,018,000	50,000	+50,000	NEW	$80.36	Q3 2015
30 Jun 2015		4.3%	-0.14%	$54,541,000	455,000	-15,000	-3.2%	$119.87	Q2 2015
31 Mar 2015		3.7%	+0.55%	$49,077,000	470,000	+70,000	+18%	$104.42	Q1 2015
31 Dec 2014		2.3%	+0.58%	$38,800,000	400,000	+100,000	+33%	$97.00	Q4 2014
30 Sep 2014		1.5%	0%	$23,430,000	300,000	0		$78.10	Q3 2014
30 Jun 2014		1.4%	+0.44%	$18,951,000	300,000	+95,000	+46%	$63.17	Q2 2014
31 Mar 2014		0.95%	+0.37%	$13,764,000	205,000	+80,000	+64%	$67.14	Q1 2014
31 Dec 2013		0.46%	0%	$8,038,000	125,000	0		$64.30	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.